Clinical Trial Update: Safety and Efficacy of Efavaleukin Alfa in Subjects With Active Rheumatoid Arthritis [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating safety and efficacy of efavaleukin alfa in active rheumatoid arthritis; study terminated with posted results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Rheumatoid Arthritis

Drugs mentioned

• Efavaleukin Alfa (efavaleukin alfa)

Snippet

Sponsor: Amgen | Conditions: Rheumatoid Arthritis RA | Phase 1, Phase 2 | Status: TERMINATED | Results posted: 2021-06-04